It is an evolution of Stalevo, a widely used oral therapeutic in earlier stages of PD. Lecigon is formulated and designed for individuals with advanced PD.

Lecigon® is a combination of levodopa, carbidopa and entacapone (ratio 4:1:4) intestinal gel for administration directly into the duodenum or upper jejunum. Lecigon® is available in cartridges …

Sep 3, 2025 · This study is a Phase III multicentric randomized controlled trial with parallel group design and waiting list in patients that have an indication to undergo intestinal L-Dopa + …

May 28, 2025 · Lecigon This information explains the Parkinson's drug Lecigon including how it works, and the benefits. Lecigon is a new drug treatment available for people with advanced …

Apr 1, 2025 · Lecigon, an intestinal gel formulation of levodopa, entacapone, and carbidopa, provided sustained motor symptom control for people with advanced Parkinson’s disease, …

This publication focuses on the most recently avail-able device-aided therapy (DAT), levodopa–enta-capone–carbidopa intestinal gel (LECIG) infusion (Lecigon®/Lecigimon®; …

Intrance’s proposed treatment approach, known as Lecigon® in the European market, combines a proprietary pharmaceutical gel formulation of a fixed-dose combination of carbidopa, …

Background: Levodopa-entacapone-carbidopa intestinal gel (LECIG) is a novel device assisted treatment option for advanced Parkinson's disease (PD). It has been available in Finland since …

Treatment of advanced levodopa-responsive Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available oral combinations of Parkinson medicinal …

Nov 26, 2021 · The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about …